| Literature DB >> 25124061 |
Claire Aguilar1, Marion Malphettes2, Jean Donadieu3, Olivia Chandesris4, Hélène Coignard-Biehler1, Emilie Catherinot5, Isabelle Pellier6, Jean-Louis Stephan7, Vincent Le Moing8, Vincent Barlogis9, Felipe Suarez4, Stéphane Gérart10, Fanny Lanternier1, Arnaud Jaccard11, Paul-Henri Consigny12, Florence Moulin13, Odile Launay14, Marc Lecuit1, Olivier Hermine4, Eric Oksenhendler2, Capucine Picard15, Stéphane Blanche16, Alain Fischer17, Nizar Mahlaoui16, Olivier Lortholary1.
Abstract
Because infectious diseases are a major source of morbidity and mortality in the majority of patients with primary immunodeficiencies (PIDs), the application of a prophylactic regimen is often necessary. However, because of the variety of PIDs and pathogens involved, and because evidence is scarce, practices are heterogeneous. To homogenize practices among centers, the French National Reference Center for PIDs aimed at elaborating recommendations for anti-infectious prophylaxis for the most common PIDs. We performed a literature review of infectious complications and prophylactic regimens associated with the most frequent PIDs. Then, a working group including different specialists systematically debated about chemoprophylaxis, immunotherapy, immunization, and recommendations for patients. Grading of prophylaxis was done using strength of recommendations (decreasing from A to D) and evidence level (decreasing from I to III). These might help infectious diseases specialists in the management of PIDs and improving the outcome of patients with PIDs.Entities:
Keywords: immunizations; immunoglobulins; primary immunodeficiency; prophylaxis
Mesh:
Year: 2014 PMID: 25124061 DOI: 10.1093/cid/ciu646
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079